Singapore markets open in 8 hours 51 minutes
Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.20 (-0.12%) Nasdaq
17,732.60 -126.08 (-0.71%) Bitcoin USD
61,599.45 +627.81 (+1.03%) CMC Crypto 200
1,278.70 -5.13 (-0.40%)
Day One Biopharmaceuticals, Inc. (DAWN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.83 |
| Open | 14.00 |
| Bid | 13.76 x 400 |
| Ask | 13.82 x 200 |
| Day's range | 13.64 - 14.08 |
| 52-week range | 9.67 - 18.07 |
| Volume | |
| Avg. volume | 1,180,853 |
| Market cap | 1.204B |
| Beta (5Y monthly) | -1.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN)
Director Saira Ramasastry sold 10,000 shares of Day One Biopharmaceuticals Inc (NASDAQ:DAWN) on June 21, 2024, as reported in a recent SEC Filing.
- Fortune
Exclusive: Day One Ventures closes its third fund at $150 million
Bucher’s Day One has closed its third fund at $150 million, Fortune can exclusively report. That far surpasses the firm’s original $100 million target, and I can only find one fund raised by a female solo GP this year that’s bigger.
- GuruFocus.com
Insider Sale at Day One Biopharmaceuticals Inc (DAWN)
York Charles N II, the COO, CFO, and Secretary of Day One Biopharmaceuticals Inc (NASDAQ:DAWN), sold 60,461 shares of the company on May 3, 2024.
© 2024 Yahoo. All rights reserved.